Actinium Pharmaceuticals, Inc.ATNMNYSE
Loading
ROIC: Strong ReturnsExpanding
Percentile Rank50
Studio
Year-over-Year Change

Return on invested capital

Latest
-60.75%
↑ 52% vs avg
Percentile
P50
Within normal range
Streak
1 yr
Consecutive growthExpanding
Average
-126.62%
Historical baseline
PeriodValueYoY Change
2024-60.75%+14.0%
2023-70.65%-115.6%
2022-32.77%+3.0%
2021-33.80%+6.3%
2020-36.08%+88.4%
2019-312.06%-18.9%
2018-262.55%-33.4%
2017-196.85%-32.0%
2016-149.08%-33.5%
2015-111.65%-